Ares Capital Set to Release Q1 Earnings: What's in the Cards?

Ares Capital is expected to report first-quarter 2026 total investment income of $769 million, up 5.1% year over year, with EPS seen at 48 cents, down 4% from last year. Key line items include interest income of $559.1 million (+6.3%), other income of $17.7 million (+4.1%), capital structuring fees of $43.9 million (-4.6%), and dividend income of $143 million, unchanged. However, the setup is cautious: the company has missed estimates in two of the last four quarters, earnings ESP is 0.00%, and the Zacks Rank is #4 (Sell), implying low odds of an earnings beat.

Analysis

ARCC’s setup is less about headline top-line growth and more about whether incremental asset yields are keeping pace with the company’s funding and credit costs. In a late-cycle private credit environment, the real signal tomorrow is net investment margin and non-accrual momentum: if originations are still strong but spreads are compressing, earnings quality can deteriorate even when revenue looks fine. The market is likely underappreciating how quickly a small move in fair-value marks or underwriting slippage can offset modest income growth in a leveraged lender.

The second-order read-through is mixed for the rest of the BDC complex. A softer print or conservative commentary would validate that competition for private credit deals is forcing looser structures, which is negative for high-multiple BDCs and more favorable for banks and insurers with lower cost of capital. Conversely, if ARCC can show stable credit performance while deploying capital into venture growth assets, that supports the idea that private lending still has room to grow — but it also intensifies future supply of capital into the same borrower cohort, which can compress returns across the space over the next 2-3 quarters.

The contrarian angle is that expectations may already be low enough that a merely in-line quarter does not need to be a stock event, especially if the market has focused too much on the earnings miss history and too little on balance-sheet resilience. The bigger risk is not tomorrow’s EPS; it is a guide-down on fee income or a cautious outlook on originations that signals deal flow is peaking. That would matter more over the next 1-2 months than the reported quarter itself because BDCs tend to reprice on forward deployment capacity, not backward-looking income.

HOPE and BUSE are the cleaner relative longs in this tape because the setup is about beat potential and less about credit-cycle sensitivity. If ARCC disappoints, capital may rotate toward regional banks with cleaner revision momentum and less mark-to-market noise, while a beat would likely be faded because the bar for private credit upside is already high.

Key Decisions for Investors

• Tactically underweight ARCC into the print; if the stock gaps up on an in-line result, use strength to reduce exposure because upside is likely capped unless management raises forward deployment guidance.
• Pair trade: long HOPE / short ARCC for the next 1-2 weeks. HOPE has cleaner earnings-surprise setup and better upside convexity if risk appetite rotates into financials; ARCC carries more event risk and lower beat probability.
• If you want to stay expressed in BDCs, buy short-dated ARCC downside protection rather than outright short stock. A put spread into earnings gives defined risk against a post-print compression in NAV/fee outlook.
• Relative-value long BUSE vs. ARCC over the next month. The market is paying for stability and estimate momentum in banks; ARCC is exposed to any signal that private credit spreads are tightening faster than asset yields.
• Watch for commentary on non-accruals and new deal spreads. If either worsens, expect a 1-2 quarter de-rating across private credit names; if both hold firm, cover any ARCC short quickly because the stock can rerate on durability, not growth.